Trending Now
NLS Pharmaceutics AG ($NLSP) Unveiling a New Frontier in CNS Disorder...
In the world of biopharmaceutical advancements, NLS Pharmaceutics AG (NASDAQ: NLSP) stands out with its recent surge in stock performance, closing up...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Zogenix, Inc. (NASDAQ:ZGNX) Gets Positive Opinion From CHMP For FINTEPLA...
Zogenix, Inc. (NASDAQ:ZGNX) announced last month that it received a Committee for Medicinal Products for Human Use (CHMP) recommending marketing approval for FINTEPLA as...
MAKE IT MODERN
LATEST REVIEWS
Infinity Pharmaceuticals Inc. (NASDAQ: INFI) Publishes Data from Trial in Urothelial...
Infinity Pharmaceuticals Inc. (NASDAQ: INFI), a clinical-stage biotechnology company, presents the updated data from its trial. The data comprises of Phase 2 MARIO-275 Trial...
MAKE IT MODERN
PERFORMANCE TRAINING
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) Publishes Data From its Phase II Study of Fostamatinib
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) announced that data from its Phase II clinical trial of fostamatinib for adult patients with warm antibody autoimmune hemolytic...
CytomX Therapeutics Inc (NASDAQ: CTMX) Announces Phase 2 Findings For Praluzatamab Ravtansine in Breast...
CytomX Therapeutics Inc (NASDAQ: CTMX) has announced that its second phase study of praluzatamab rvtansine in individuals with hormone receptor-positive (HR+)/human epidermal growth factor...
Bright Health Group Inc (NYSE: BHG) Reports a 275% Revenue Increase in The...
Bright Health Group Inc (NYSE: BHG) recently released its financial and operational results for the second quarter of 2021. BHG is a diversified health...
Nexoptic Technology Corp (OTCMKTS:NXOPF) surges on increased volume and Qualcomm news (QCOM)
Shares of Nexoptic Technology Corp (OTCMKTS:NXOPF) have surged over 155% in the past 6 months. At the time of this publication, NXOPF...
Reason why ReShape Lifesciences Stock (RSLS) is surging
ReShape Lifesciences Stock More than doubled and last traded at $17.04+10.74 (+170.48%). However, the stock lost quite a bit of steam after...
MAKE IT MODERN
